Alzheimer’s disease (AD) is a progressive neurodegenerative disorder classically characterized by the accumulation of amyloid beta (Aβ) plaques and hyperphosphorylated tau aggregates that disrupt synaptic function, ultimately culminating in synaptic decline and neurodegeneration [1]. Here, MAPT is linked to Alzheimer disease.